Latest Cash Management News

Page 2 of 26
Blackpearl Group more than doubled annual recurring revenue to NZ$26.8 million in FY26, but the growth came alongside an NZ$17.8 million loss and a formal material uncertainty over its ability to continue as a going concern. The company says cost reductions, faster cash conversion and its refinanced BNZ facility can support the next phase.
Sophie Babbage
Sophie Babbage
11 Sept 2026
Fitzroy River Corporation reported a modest loss for FY26, with a key highlight being a $12.27 million disputed payment from Endura Mining related to its Snowy River Gold Project royalty. The company has initiated court proceedings in New Zealand to clarify the validity of this buyout option while exploring potential sale of its Bowdens Silver royalty.
Maxwell Dee
Maxwell Dee
4 Sept 2026
Invex Therapeutics posted a $1.35 million net loss for FY2026, driven by expanded R&D efforts and a deepening collaboration with Tessara Therapeutics targeting neurological diseases including Alzheimer’s. The company renewed its orphan drug status in Europe and restructured its board during the year.
Ada Torres
Ada Torres
31 Aug 2026
Talius Group’s HY2026 results reveal a strategic pivot towards higher-margin software subscriptions, with gross margin surging to 51% despite a 19% revenue dip due to hardware deployment timing. Active subscriptions topped 53,200, underpinning a $3.26 million ARR, while cash burn shrank dramatically.
Victor Sage
Victor Sage
28 Aug 2026
Summerset Group Holdings posted a 92% jump in half-year net profit to NZ$171.4 million, driven by strong sales and disciplined cash management. The company also updated its dividend policy to align payouts with operating cash flow, reflecting its maturing portfolio and cautious growth approach.
Eva Park
Eva Park
27 Aug 2026
Xenitra Limited has secured A$1.5 million through a discounted share placement to accelerate growth in higher-margin OTC medicines, FSMP, and tokenised FMCG sales. The capital will fund inventory expansion, supplier fulfilment, and ecommerce activation as the company shifts from low-margin distribution to a diversified healthcare platform.
Victor Sage
Victor Sage
24 Aug 2026
Cyclopharm Limited posted a fifth consecutive record half-year revenue of $17.5 million, propelled by a 74% jump in US Technegas® sales and a doubling of revenue-generating US sites. New US clinical guidelines naming Technegas® as the preferred ventilation imaging agent underpin a robust growth outlook despite a wider net loss.
Ada Torres
Ada Torres
24 Aug 2026
Audeara Limited has raised $1.26 million through a two-tranche share placement to back its expanding technology licensing and retail channels, following a year of revenue growth and reduced cash burn.
Ada Torres
Ada Torres
21 Aug 2026
Audalia Resources plans a $450,000 share placement to advance its Medcalf project and bolster working capital, while continuing to explore further funding options for regulatory approvals.
Maxwell Dee
Maxwell Dee
17 Aug 2026
Bell Financial Group surged to a $21.7 million half-year profit, more than doubling its net profit on stronger markets and the launch of its Bell Potter Private Wealth platform. The company also lifted its interim dividend by 67%, reflecting confidence in its diversified financial services model.
Claire Turing
Claire Turing
13 Aug 2026
Elixinol Wellness (ASX: EXL) has posted a record quarterly revenue of A$4.3 million alongside a 45% gross margin, marking a clear shift from its US CBD origins to a diversified Australian wellness platform. Cost reductions and disciplined cash flow management underpin the company’s readiness to scale.
Victor Sage
Victor Sage
7 Aug 2026
True North Copper (ASX:TNC) reported strong progress in Q4 FY2026, expanding its Mt Oxide copper system and consolidating its Cloncurry assets ahead of a key Pre-Feasibility Study.
Maxwell Dee
Maxwell Dee
30 July 2026

Browse the archive

Full archive